​

Editas Medicine Ownership | Who Owns Editas Medicine?


OverviewForecastRevenueFinancialsChart

Editas Medicine Ownership Summary


Editas Medicine is owned by 116.90% institutional investors, 0.20% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 12.07% of EDIT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.19% of its assets in Editas Medicine shares.

EDIT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEditas Medicine116.90%0.20%-17.10%
SectorHealthcare Stocks 129.28%12.06%-41.34%
IndustryBiotech Stocks 181.42%11.67%-93.09%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de14.40M12.07%$37.01M
Tcg crossover management11.11M11.35%$36.00M
Blackrock7.78M9.50%$36.34M
Vanguard group8.21M9.11%$16.83M
Adar1 capital management8.89M9.08%$28.80M
Commodore capital lp8.89M9.08%$28.80M
Ra capital management8.89M9.08%$28.80M
State street7.04M5.90%$18.09M
Paradigm biocapital advisors lp5.59M5.71%$18.10M
Vanguard capital management6.07M5.09%$15.61M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Commodore capital lp8.89M1.72%$28.80M
Adar1 capital management8.89M1.32%$28.80M
Opaleye management3.86M1.13%$12.51M
Vivo capital3.56M1.01%$9.14M
Tcg crossover management11.11M0.87%$36.00M
Highvista strategies1.11M0.75%$2.85M
Paradigm biocapital advisors lp5.59M0.34%$18.10M
Logos global management lp2.22M0.31%$7.20M
Ra capital management8.89M0.25%$28.80M
Turner financial group44.96K0.12%$115.54K

Top Buyers

HolderShares% AssetsChange
Tcg crossover management11.11M0.87%11.11M
Ra capital management8.89M0.25%8.89M
Adar1 capital management8.89M1.32%8.89M
Commodore capital lp8.89M1.72%8.89M
Paradigm biocapital advisors lp5.59M0.34%5.59M

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp---4.90M
Avidity partners management lp---1.47M
Pictet asset management sa---1.16M
Monaco asset management sam---1.07M
Mackenzie financial---878.04K

New Positions

HolderShares% AssetsChangeValue
Tcg crossover management11.11M0.87%11.11M$36.00M
Adar1 capital management8.89M1.32%8.89M$28.80M
Commodore capital lp8.89M1.72%8.89M$28.80M
Ra capital management8.89M0.25%8.89M$28.80M
Paradigm biocapital advisors lp5.59M0.34%5.59M$18.10M

Sold Out

HolderChange
Gps wealth strategies group-2.00
Jpl wealth management-4.00
Pacific capital wealth advisors-5.00
Sittner & nelson-6.00
Quintet private bank (europe)-6.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2026228-139,451,13316.03%1161.15%107-6.14%5636.59%
Jun 30, 20262212.79%120,168,106131.67%1223.59%11313.00%40-14.89%
Mar 31, 2026151-25.98%34,771,706-30.36%391.28%69-8.00%27-54.24%
Dec 31, 2025163-20.87%39,288,742-8.85%431.67%54-28.00%48-17.24%
Sep 30, 2025197-43,075,9754.21%512.13%69-9.21%5711.76%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv4.89M3.19%-
Vanguard Morn Total Stk Mkt Idx Investor4.89M3.19%-
Vanguard US Total Market Shares ETF2.59M3.12%-
State Street® SPDR® S&P® Biotech ETF4.54M2.96%118.77K
Vanguard MStar Total Stk Mkt Idx Invest4.39M2.86%-499.28K
iShares Russell 2000 ETF3.99M2.60%-
Pictet Biopharmaceutical Mother1.15M1.38%42.67K
Vanguard Strategic Equity Inv2.03M1.32%-
Vanguard Small Cap Index1.04M1.26%2.50K
Nuveen Quant Small Cap Equity R61.68M1.09%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 11, 2026O'Neill Gilmore Neil CEOSell$51.12K
Nov 11, 2026Burkly Linda EVP, CHIEF SCIENTIFIC OFFICERSell$18.87K
Sep 03, 2026Burkly Linda EVP, CHIEF SCIENTIFIC OFFICERSell$2.15K
Sep 03, 2026Parison Amy SVP, Chief Financial OfficerSell$1.38K
Sep 03, 2026O'Neill Gilmore Neil CEOSell$15.56K

Insider Transactions Trends


DateBuySell
2026 Q4-2
2026 Q3-5
2026 Q2-3
2026 Q1-3
2025 Q4-3

EDIT Ownership FAQ


Who Owns Editas Medicine?

Editas Medicine shareholders are primarily institutional investors at 116.90%, followed by 0.20% insiders and -17.10% retail investors. The average institutional ownership in Editas Medicine's industry, Biotech Stocks , is 181.42%, which Editas Medicine falls below.

Who owns the most shares of Editas Medicine?

Editas Medicine’s largest shareholders are Blackrock funding, inc. /de (14.4M shares, 12.07%), Tcg crossover management (11.11M shares, 11.35%), and Blackrock (7.78M shares, 9.50%). Together, they hold 32.92% of Editas Medicine’s total shares outstanding.

Does Blackrock own Editas Medicine?

Yes, BlackRock owns 9.50% of Editas Medicine, totaling 7.78M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 36.34M$. In the last quarter, BlackRock decreased its holdings by -50.264K shares, a -0.64% change.

Who is Editas Medicine’s biggest shareholder by percentage of total assets invested?

Commodore capital lp is Editas Medicine’s biggest shareholder by percentage of total assets invested, with 1.72% of its assets in 8.89M Editas Medicine shares, valued at 28.8M$.

Who is the top mutual fund holder of Editas Medicine shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Editas Medicine shares, with 3.19% of its total shares outstanding invested in 4.89M Editas Medicine shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools